EDB works with Johnson & Johnson to innovate SG’s life sciences | Asian Business Review
460 views

EDB works with Johnson & Johnson to innovate SG’s life sciences

The collaboration backs early-stage firms and fast track innovative medicines.

Johnson & Johnson Innovation and the Singapore Economic Development Board (EDB) will collaborate to support life sciences innovation in the city-state. 

“This collaboration is the first of its kind and will leverage Johnson & Johnson Innovation – JLABS’ services and innovation resources aimed at boosting the region’s innovation output,” read the statement.

JLABS will support early-stage firms with a location in Singapore to speed up their discoveries into innovative medicines, medical technologies, and healthcare solutions. 

JLABS will also collaborate with local incubators and other strategic partners in the ecosystem on venture and talent development offerings to develop employment and commercialisation opportunities for early-stage companies.

The partnership complies with J&J’s commitment to speed up science and technology development in the Asia Pacific region, with the goal of addressing critical healthcare needs.

Follow the link s for more news on

Join Asian Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

Key investment opportunities in autonomous shipbuilding market
Companies should capitalise on the advancing autonomous maritime technologies.
What lies ahead of the global medical device industry?
Tariffs are complicating regulatory compliance and driving costs for manufacturers.
Healthcare
Global solar installations reach nearly 600 GW in 2024
Last year’s additional capacity slightly increased from the previous 12 months.